Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
52 hedge funds and large institutions have $30.7M invested in Windtree Therapeutics Inc in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 11 closing their positions.
234% more call options, than puts
Call options by funds: $317K | Put options by funds: $95K
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 58 → 52 (-6)
49% less capital invested
Capital invested by funds: $59.8M → $30.7M (-$29M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$219K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$123K |
| 3 |
D.E. Shaw & Co
New York
|
+$120K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$78.4K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$2.98M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$1.26M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$468K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$293K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$290K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCM
51
Rotella Capital Management
Bellevue,
Washington
| – | -$23K | -1,394 | Closed |
|
|
BIM
52
BlackRock Investment Management
Wilmington,
Delaware
| – | -$17K | -1,025 | Closed |
|
53
Simplex Trading
Chicago,
Illinois
| – | -$13.9K | -990 | -100% |
|
|
TSS
54
Two Sigma Securities
New York
| – | -$16K | -988 | Closed |
|
|
ST
55
Spot Trading
Chicago,
Illinois
| – | -$9K | -518 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$407 | +29 | New |
|
WINT Hedge Fund Activity: Q2 2015 in Review
52 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2015, worth a combined $30.7M — down 49% from $59.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of WINT and 5 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 16 added.
The largest buyer was Group One Trading, adding an estimated $219K. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $2.98M sold.
- 52 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2015, down from 58 in Q1 2015.
- Funds reported $30.7M of Windtree Therapeutics Inc stock for Q2 2015, down 49% quarter-over-quarter.
- 5 funds opened new Windtree Therapeutics Inc positions in Q2 2015 and 11 closed out, a net change of -6 holders.
- The largest Windtree Therapeutics Inc buyer in Q2 2015 was Group One Trading, an estimated $219K added.
- The largest Windtree Therapeutics Inc seller in Q2 2015 was Ghost Tree Capital, an estimated $2.98M sold.
Based on aggregated 13F filings for Q2 2015.